2. Others

Others

Others

Related Products

PDF 58.49 MB

There are a number of inhibitors, agonists, and antagonists which we cannot make precise classification because the research area is still unknown.

Others Related Products (73873):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-115493
    TIQ-15 1380336-17-3 98%
    TIQ-15 is a potent CXCR4 antagonist with an IC50 value of 6 nM for CXCR4 Ca2+ flux. TIQ-15 inhibits CYP450 2D6 with an IC50 value of 0.32 μM.
    TIQ-15
  • HY-115533
    LBL1 1605301-58-3 98%
    LBL1 is a ligand for lamins (especially lamin A, LA) in the nucleus, that stabilizes the oligomeric state of LA, and affects the assembly state of LA. LBL1 can be used to study the assembly state and dynamic changes of LA.
    LBL1
  • HY-115577
    Mitochonic acid 35 1611470-23-5 98%
    Mitochonic acid 35 is an IAA analogue with cytoprotective effects.
    Mitochonic acid 35
  • HY-115689
    Maohuoside B 849834-04-4 98%
    Maohuoside B is a flavonoid, that can be isolated from Epimedium koreanum Nakai.
    Maohuoside B
  • HY-115692
    2-Coumaranone-1-L 1887057-34-2 98%
    2-Coumaranone-1-L serves as a chemiluminescent probe. Under alkaline conditions and in the presence of oxygen, 2-Coumaranone-1-L is capable of undergoing chemiluminescence, which enables its application as a chemiluminescent substrate in biochemical assays. 2-Coumaranone-1-L exhibits its maximum emission wavelength at 442 nm. 2-Coumaranone-1-L is utilized in research within the realm of bioanalysis.
    2-Coumaranone-1-L
  • HY-115705S
    1,2,3-Tri-10(Z)-Heptadecenoyl Glycerol-d5 98%
    1,2,3-Tri-10(Z)-Heptadecenoyl Glycerol-d5 is the deuterium labeled 1,2,3-Tri-10(Z)-Heptadecenoyl Glycerol.
    1,2,3-Tri-10(Z)-Heptadecenoyl Glycerol-d5
  • HY-115727
    BET-IN-1 2727161-43-3 98%
    BET-IN-1 is a potent BET inhibitor that has excellent brain penetration and reasonable metabolic stability.
    BET-IN-1
  • HY-115736
    Xanthosine-5'-Triphosphate 6253-56-1 98%
    Xanthosine-5'-Triphosphate (5'-XTP), a nucleotide, is produced by deamination of purine bases. Xanthosine-5'-Triphosphate is a substrate of inosine triphosphate pyrophosphatase (ITPase).
    Xanthosine-5'-Triphosphate
  • HY-115749A
    (Rac)-Luciferin 6′-methyl ether sodium 646450-23-9 98%
    D-Luciferin 6′-methyl ether (6′-Methoxyluciferin; compound 19a) sodium is a potent luciferase from the North American firefly Photinus pyralis (PpyLuc) inhibitor with an IC50 of 0.1 μM. D-Luciferin 6′-methyl ether, a D-luciferin analog, shows non-specific interactions at ATP- and luciferin-binding sites of the PpyLuc active site.
    (Rac)-Luciferin 6′-methyl ether sodium
  • HY-115756
    4-Maleimidosalicylic acid 19232-43-0 98%
    4-Maleimidosalicylic acid is a polar maleimide, and does not suppress IL-2 production in JURKAT T cells.
    4-Maleimidosalicylic acid
  • HY-115774
    5-HT4R agonist-1 2231302-46-6 98%
    5-HT4R agonist-1 is an active compound.
    5-HT4R agonist-1
  • HY-115796
    VU0477886 1926222-30-1 98%
    VU0477886 is a metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator with potent activating activity on mGlu4 (EC50 = 95nM, 89% Glu Max), good pharmacokinetic characteristics (brain: plasma Kp = 1.3), and significant therapeutic efficacy in Parkinson's disease models.
    VU0477886
  • HY-115824
    7ETMC 1370702-83-2 98%
    7ETMC is a cytochrome P450 inhibitor with selective inhibition of human cytochrome P450s 1A1 and 1A2. 7ETMC has inhibitory effects on P450s 1A1 and 1A2 with IC?? values of 0.46μM and 0.50μM, respectively, within the first six minutes, and has no inhibitory activity against P450s 2A6 and 2B1. Except for 7-ethynyl-3-methyl-4-phenylcoumarin, the remaining inhibitors show mechanism-based inhibition of P450s 1A1 and 1A2.
    7ETMC
  • HY-115827
    AH22921 74480-23-2 98%
    AH22921 is an EP4 prostaglandin receptor antagonist with the activity of antagonizing the activation of adenylate cyclase by prostaglandins in CHO cells. AH22921 can shift the PGE2 concentration-response curve to the right in CHO cells. It is a non-competitive antagonist that is selective for EP4 receptors and has an antagonistic effect on EP4 receptors in CHO cells, but does not affect the PGE2 concentration-response curve in NPE cells containing EP2 receptors.
    AH22921
  • HY-115837
    DHPCC-9 1192248-37-5 98%
    DHPCC-9 acts as an inhibitor of Pim kinase.
    DHPCC-9
  • HY-115839
    Detajmium 47719-70-0 98%
    Detajmium (Tachmalcor free base) is a Na?-channel blocker with activity to inhibit ventricular conduction and refractoriness. Detajmium (0.3μM) prolongs intraventricular conduction time comparable to propafenone (0.3μM) during sinus rhythm, but the time constant for reaching steady state during rapid ventricular pacing is significantly longer for Detajmium, indicating a unique temporal profile for its heart rate-dependent effects.
    Detajmium
  • HY-115850
    Ornithine-methotrexate 80407-73-4 98%
    Ornithine-methotrexate is an active compound.
    Ornithine-methotrexate
  • HY-115858
    SU-13197 12379-49-6 98%
    SU-13197 is an active compound.
    SU-13197
  • HY-115871A
    (Rac)-PDE4-IN-4 98%
    (Rac)-PDE4-IN-4 is the diastereomer mixture of PDE4-IN-4 (HY-115871). PDE4-IN-4 is a dual M3 (pIC50 = 10.2) antagonist-PDE4 (pIC50 = 8.8) inhibitor for the inhaled research of pulmonary diseases.
    (Rac)-PDE4-IN-4
  • HY-115914
    Lipid-lowering agent-1 2304859-34-3 98%
    Lipid-lowering agent-1 is a potent lipid-lowering agent. Lipid-lowering agent-1 has significant pharmacological effects on the inhibition of low-density lipoprotein cholesterol (LDLC) and promotion of high-density lipoprotein cholesterol (HDLC) production. Lipid-lowering agent-1 shows potent hypolipidemic effect in high-fat diet rats.
    Lipid-lowering agent-1